Bio-Path Holdings, Inc.
BPTH
$0.10
-$0.02-16.67%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -59.34% | 56.44% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 40.76% | 23.47% | |||
| Operating Income | -40.76% | -23.47% | |||
| Income Before Tax | -61.19% | -3.60% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -61.19% | -3.60% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -61.19% | -3.60% | |||
| EBIT | -40.76% | -23.47% | |||
| EBITDA | -40.48% | -24.29% | |||
| EPS Basic | -36.99% | 36.69% | |||
| Normalized Basic EPS | -37.00% | 36.71% | |||
| EPS Diluted | -36.99% | 36.69% | |||
| Normalized Diluted EPS | -37.00% | 36.71% | |||
| Average Basic Shares Outstanding | 17.64% | 63.66% | |||
| Average Diluted Shares Outstanding | 17.64% | 63.66% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||